Access to systemic anti-cancer therapies for women with secondary breast cancer—protocol for a mixed methods systematic review

BACKGROUND: It is well recognised that access and receipt of appropriate guideline recommended treatment with systemic anti-cancer therapies for secondary breast cancer is a key determinant in overall survival. Where there is disparity in access this may result in unwarranted variation and disparity...

Descripción completa

Detalles Bibliográficos
Autores principales: Pearson, Sally Anne, Taylor, Sally, Marsden, Antonia, Yorke, Janelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299679/
https://www.ncbi.nlm.nih.gov/pubmed/34294151
http://dx.doi.org/10.1186/s13643-021-01761-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299679/
https://www.ncbi.nlm.nih.gov/pubmed/34294151
http://dx.doi.org/10.1186/s13643-021-01761-y

Ejemplares similares